SEARCH Contact

Case Study

Transferring a Legacy Urological Device Production Line to the EU With Zero Disruption

From Fragmented Legacy Program to CE-Compliant, Fully Operational EU Transfer

A Fortune 100 medical device manufacturer needed to transfer a legacy U.S. production line for a single-use urological diagnostic device to a European Union facility without interrupting ongoing operations, compromising product quality, or missing regulatory milestones. Ascential assumed end-to-end ownership of the program and delivered a controlled, CE-compliant transfer across 150 components and 32 unique equipment build packages.

Components, fixtures, and systems transferred

150 0

Unique equipment build packages managed

32 0

The Challenge

Production line transfers for commercially active medical devices are among the most operationally sensitive programs in manufacturing. Every decision carries risk: delay the transfer and supply continuity is threatened; rush the execution and compliance gaps emerge. For a complex legacy line, those risks multiply.

The client’s U.S.-based production line for a single-use urological diagnostic device required full relocation to an EU manufacturing site. The program presented a convergence of compounding challenges: approximately 150 components, fixtures, and systems spanning 32 distinct equipment build packages needed to be transferred, validated, and made operational at a receiving site with limited familiarity with the existing equipment. Layered on top were significant documentation issues; outdated drawings, fixture-to-product mismatches, and legacy design gaps that created direct barriers to CE compliance. The client’s goals were clear:

Transfer Without Disrupting Ongoing Operations

Execute a complex line transfer from a U.S. facility to an EU site without interrupting the production of active, commercially distributed devices.

Manage a High-Volume, Multi-Package Program

Coordinate approximately 150 components across 32 distinct equipment build packages under a single integrated project schedule.

Achieve CE Marking with Legacy Documentation Gaps

Deliver CE-compliant systems despite outdated documentation, drawing-to-product mismatches, and obsolete fixtures requiring redesign.

Enable Rapid Ramp-Up at the Receiving Facility

Prepare the EU site, which had limited familiarity with the transferred equipment, to achieve operational readiness quickly and safely.

Ascential's Solution

Ascential assumed full end-to-end ownership of the line transfer under a single integrated project schedule, eliminating the multi-vendor fragmentation that typically characterizes programs of this complexity. Rather than treating procurement, documentation, validation, and regulatory support as parallel workstreams managed by separate organizations, Ascential consolidated all program functions under one team and one schedule.

By taking ownership of the full transfer lifecycle from the outset, Ascential was able to resolve legacy design issues, manage scope changes, and maintain milestone commitments without disrupting the client’s active commercial operations.

CE marking compliance was a central focus. Ascential prepared machinery risk assessments and complete documentation packages aligned to EU regulatory requirements. Where legacy fixtures were found to be obsolete or mismatched against current product drawings, Ascential redesigned and fabricated replacements directly — closing documentation gaps that would otherwise have blocked compliance.

To maintain program visibility and control across a complex, multi-stakeholder engagement, Ascential implemented structured engineering governance: live Q&A tracking and weekly executive reporting ensured that scope changes, open issues, and schedule risks were uncovered and addressed in real time rather than discovered late in the process.

Prior to shipment, Ascential conducted in-person factory acceptance testing (FAT) demonstrations to verify equipment performance and identify any remaining issues before transfer. On-site operator training was completed at the EU receiving facility to build equipment familiarity and accelerate ramp-up — reducing the time and risk associated with bringing a new site to full operational capability.

Technical Capabilities Delivered

Ascential’s program delivery spanned a broad set of technical and operational functions, all executed under unified project management:

Capability	What Ascential Built
Program Management	End-to-end ownership under a single integrated project schedule spanning all 32 equipment build packages
CE Marking & Regulatory Support	Machinery risk assessments and complete CE documentation packages prepared for EU market compliance
Legacy Documentation Remediation	Rapid redesign and fabrication of obsolete fixtures to resolve drawing-to-product mismatches and close documentation gaps
Engineering Governance	Structured live Q&A tracking and weekly executive reporting to maintain schedule visibility and stakeholder alignment
Procurement & Validation	Centralized procurement, equipment validation, and documentation to eliminate multi-vendor fragmentation and reduce program risk
Factory Acceptance Testing	In-person FAT demonstrations conducted prior to shipment to verify performance and accelerate EU site readiness
Operator Training	On-site operator training delivered at the receiving EU facility to build familiarity with transferred equipment and workflows

Key Results

Ascential transformed a high-complexity, high-risk legacy line transfer into a controlled, compliant program execution. The completed transfer delivered across every critical dimension:

150 components, fixtures, and systems transferred across a legacy production line, fully documented and validated for EU operations.
32 unique equipment build packages managed under a single integrated project schedule, eliminating multi-vendor coordination risk.
CE compliance achieved through machinery risk assessments, complete documentation packages, and rapid resolution of legacy drawing-to-product mismatches.
Zero disruption to ongoing operations — the line transfer was executed without interrupting commercial supply of an actively distributed device.
EU site ramp-up accelerated through in-person FAT demonstrations and on-site operator training prior to and following equipment shipment.

Why It Matters

Single-use diagnostic devices designed for minimally invasive clinical use demand consistent manufacturing quality. For the patients who depend on them, and for the clinicians who rely on them, any lapse in manufacturing performance or regulatory compliance carries direct consequences.

For a medical device manufacturer managing a geographically complex production footprint, a line transfer is not simply a logistics challenge — it is a regulatory, operational, and quality event. Executing it without disruption requires a partner capable of owning the full program scope: resolving legacy documentation issues, managing procurement and validation, and preparing the receiving site to operate at speed.

Ascential’s role extended well beyond equipment relocation. By consolidating program ownership, resolving legacy design gaps, and delivering structured governance throughout, Ascential protected the client’s commercial continuity and compliance posture at every stage of the transfer — from initial planning through EU site activation.